Adriamycin-induced glomerulosclerosis in the rat.

Area of Science:

• Nephrology
• Experimental Pathology
• Toxicology

Background:

• Sustained proteinuria is a hallmark of various kidney diseases.
• Focal segmental glomerulosclerosis (FSG) is a progressive glomerular injury.
• Adriamycin (ADR) is a chemotherapeutic agent that can induce kidney damage.

Purpose of the Study:

• To investigate the long-term effects of ADR-induced proteinuria on FSG development.
• To explore the role of tubulointerstitial changes in FSG pathogenesis.

Main Methods:

• 50 Sprague-Dawley rats were injected with ADR (5 mg/kg).
• Rats were monitored for proteinuria, FSG, tubular casts, and interstitial inflammation for nine months.

Main Results:

• After six months, 60% of ADR-treated rats developed mild FSG, associated with tubular casts and interstitial inflammation.
• Glomerulosclerosis was consistently linked to tubulointerstitial lesions.
• At nine months, all rats showed FSG and renal insufficiency, with severe tubulointerstitial changes.

Conclusions:

• ADR-induced proteinuria is a viable model for studying glomerular sclerosis.
• Tubulointerstitial changes, particularly tubular casts, are critical drivers of FSG development and progression.
• The pathogenesis of ADR-induced FSG may differ from other experimental models, emphasizing the role of tubulointerstitial injury.